Medical experts in the United States have given their approval for the emergency use of the COVID-19 vaccine, with 17 in the medical team of experts approving the move, four being against the move and one absent during the meeting on Thursday. The decisions were made based on the totality of scientific evidence available, whether the benefits of the Pfizer-BioNTech Covid-19 vaccine outweigh its risk for use in individuals 16 years of age and older.
This comes after UK’s medical regulator issued an allergy warning against Pzifer vaccine against the deadly COVID-19, after two reported adverse allergic reactions, though the vaccine has been approved in Britain.
The US Food and Drug Administration (FDA) will now approve an official Emergency Use Authorization (EUA) for the Pfizer and BioNTech COVID-19 vaccine. This means that the vaccine will be administered to people in special circumstances including frontline workers, the elderly and others who suffer from comorbidity issues.
The Pfizer-BioNTech vaccine is an mRNA vaccine where it provides a set of instructions to a person’s cells to prompt them to begin creating antibodies that are effective against the SARS-CoV-2 virus that leads to COVID-19.
Apart from the US and UK, other countries to have approved the vaccine are Canada, Bahrain and Saudi Arabia after completing phase 3 of clinical trials. Russian and Chinese vaccines are already being administered on a large scale. However, full proof clinical trials have not yet been completed.